Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2005
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1516057A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity
03/23/2005EP1516047A1 Purified pkb ser 473 kinase and uses thereof
03/23/2005EP1515987A2 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
03/23/2005EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515973A1 Porphyrin-polyamine conjugates for cancer therapy
03/23/2005EP1515960A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515952A2 Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515754A2 Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
03/23/2005EP1515751A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
03/23/2005EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof
03/23/2005EP1515745A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515740A1 Aqueous preparation containing oligopeptides and etherified cyclodextrin
03/23/2005EP1515736A1 Compositions against inflammatory processes
03/23/2005EP1515725A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1404319A4 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
03/23/2005EP1311285B1 Liquid pharmaceutical composition containing an erythropoietin derivative
03/23/2005EP1289977B1 Triterpenoid derivatives and their use as antiproliferative agents
03/23/2005EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules
03/23/2005EP1198478B1 Somatostatin analogs and their use for the treatment of cancer
03/23/2005EP1181382B1 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
03/23/2005EP1152764A4 Compositions and methods for use in targeting vascular destruction
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005EP1104305B1 Use of angiotensin in the treatment of cancer metastasis
03/23/2005EP1091924A4 Novel retinoids and use thereof
03/23/2005EP0938323B1 Treatment of highly vascular tumours with dextrin sulfates
03/23/2005EP0845005B1 Traf inhibitors
03/23/2005EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein
03/23/2005EP0772456B1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement
03/23/2005CN1599867A Immunocytokines with modulated selectivity
03/23/2005CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel
03/23/2005CN1599750A Cytotoxic protein and utilization thereof
03/23/2005CN1599744A Beta -2'-or 3'-halonucleosides
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
03/23/2005CN1599728A 1, 2, 4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr)
03/23/2005CN1599627A Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
03/23/2005CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/23/2005CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1597939A Multifunctional anticancer recombined adenovirus
03/23/2005CN1597696A Biological Function of new DRAB type zinc finger protein 2HP 333
03/23/2005CN1597677A Compounds and methods for modulation of estrogen receptors
03/23/2005CN1597676A Jujube kernel saponin derivative and its preparation method and use
03/23/2005CN1597674A 1, 3-di[N-(2-methoxy) phenyl] piperazine]-1- acetone hydrochloride and its preparation method and application
03/23/2005CN1597671A Quinazoline deriative and preparation method and bioactivity
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1596985A New clinical parameters for determining haematics toxicity prior to radioimmunotherapy
03/23/2005CN1596977A Anti gonadoliberin resisting hormone nucleic acid vaccine and its preparation method
03/23/2005CN1596966A Compound formule chinaroot greenbrier capsule and its preparation method
03/23/2005CN1596965A Compound formula chinaroot greenbrier granules and its preparation method
03/23/2005CN1596964A Compound formula chinaroot greenbrier tablet and its preparation method
03/23/2005CN1596936A Traditional Chinese medicine for treating cancer and its preparation method
03/23/2005CN1596927A Medicine for treating cancer
03/23/2005CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method
03/23/2005CN1596881A Application Hehoupu phenol in preparing antitumour multi medicinal tolerant medicine
03/23/2005CN1194092C Medusa cystatin Protease inhibitor gene, and expression and use therof
03/23/2005CN1194090C Growth factor and genetic sequence for encoding same
03/23/2005CN1194015C Effective renaturation liquid of recombinant human interon inclusion boby and renaturation method
03/23/2005CN1194014C Coupled cmpound of hematopoietin and polyethylene glycol
03/23/2005CN1193793C Diarylprophin photosensitizer and its preparing process and usage
03/23/2005CN1193791C Ordered molecualr presentation of antigens. method of preparation and use
03/23/2005CN1193789C Application of thyroxine for treating tumor
03/23/2005CN1193759C Sustained release and implantation type cis-platinum medicine and method for preparing same
03/23/2005CN1193746C Substituted nitrobenzene derimative for medicine and other use
03/23/2005CN1193741C Preparation method of water soluble anticancer medical microsphere
03/22/2005US6870052 Preparation of thioarabinofuranosyl compounds and use thereof
03/22/2005US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
03/22/2005US6870028 Biologically active peptides and compositions, their use
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869971 UCS1025 derivatives
03/22/2005US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate
03/22/2005US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869944 Method for treating a patient with neoplasia by treatment with a platinum coordination complex
03/22/2005US6869941 Combination of drospirenone and an estrogen sulphamate for HRT
03/22/2005US6869789 Heparinase III and uses thereof
03/22/2005US6869607 Vaccine formulations
03/22/2005US6869605 Anticarcinogenic agents
03/22/2005US6869588 Stimulus sensitive gel with radioisotope and methods of making
1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 2211